You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

SODIUM BICARBONATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for sodium bicarbonate and what is the scope of freedom to operate?

Sodium bicarbonate is the generic ingredient in three branded drugs marketed by Amneal, Anthea Pharma, Exela Pharma, Fresenius Kabi Usa, Hospira, Intl Medication Sys, Long Grove Pharms, Omnivium Pharms, Steriscience, Abbott, and Mallinckrodt Inc, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for sodium bicarbonate. Twenty suppliers are listed for this compound.

Summary for SODIUM BICARBONATE
Drug Prices for SODIUM BICARBONATE

See drug prices for SODIUM BICARBONATE

Recent Clinical Trials for SODIUM BICARBONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nextrast, Inc.PHASE1
University of CopenhagenNA
Copenhagen Trial Unit, Center for Clinical Intervention ResearchNA

See all SODIUM BICARBONATE clinical trials

US Patents and Regulatory Information for SODIUM BICARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott SODIUM BICARBONATE IN PLASTIC CONTAINER sodium bicarbonate SOLUTION;INTRAVENOUS 019443-001 Jun 3, 1986 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Intl Medication Sys SODIUM BICARBONATE sodium bicarbonate SOLUTION;INTRAVENOUS 203449-001 Sep 19, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa SODIUM BICARBONATE sodium bicarbonate SOLUTION;INTRAVENOUS 206688-002 Aug 25, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal SODIUM BICARBONATE sodium bicarbonate SOLUTION;INTRAVENOUS 217523-001 Jan 13, 2026 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira SODIUM BICARBONATE sodium bicarbonate SOLUTION;INTRAVENOUS 202494-001 Mar 6, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira SODIUM BICARBONATE sodium bicarbonate SOLUTION;INTRAVENOUS 202981-001 Mar 4, 2016 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium Bicarbonate

Last updated: February 19, 2026

What is the current market size and projected growth for sodium bicarbonate?

Sodium bicarbonate, commonly known as baking soda, is a versatile chemical used across pharmaceutical, industrial, food, and consumer sectors. The global market size was valued at approximately $1.2 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030, reaching an estimated $1.7 billion by 2030. Expansion is driven by increasing demand in healthcare applications, food processing, and industrial cleaning.

Year Market Size (USD Billion) Growth Rate (%)
2022 1.2
2023 1.25 4.2
2025 1.4 4.0
2030 1.7 4.3

Sources: Market Research Future, 2023[1]

Where are key regional markets for sodium bicarbonate?

North America and Europe dominate the sodium bicarbonate market due to established pharmaceutical industries and strict regulatory standards. North America accounted for about 35% of the market share in 2022, supported by high healthcare spending and manufacturing capacity.

Asia-Pacific exhibits the fastest growth, at a CAGR of 5.2%, driven by expanding pharmaceutical manufacturing, food processing industries, and economic growth in China and India. China alone is estimated to produce nearly 40% of global sodium bicarbonate, with local demand increasing substantially.

Region Market Share (2022) CAGR (2023–2030)
North America 35% 3.8%
Europe 30% 3.5%
Asia-Pacific 25% 5.2%
Rest of World 10% 3.9%

What are the primary factors influencing sodium bicarbonate demand?

Healthcare Sector: Used as an antacid, in dialysis, and for urinary pH regulation. Growing prevalence of gastrointestinal disorders and rising dialysis procedures boost demand.

Food Industry: Acts as a leavening agent, pH buffer, and preservative. Expanding bakery, snack, and beverage segments expand application volume.

Industrial Applications: Serves as a cleaning agent, fire extinguisher component, and in textile processing. Industrial output growth in emerging economies drives consumption.

Environmental Applications: Used for water treatment and waste management, increasingly important as regulations tighten worldwide.

What competitive factors shape the market?

Pricing: Sodium bicarbonate remains inexpensive, with raw material costs fluctuating based on energy prices and raw material supply chains. Producer prices ranged from $1.50 to $2.00 per kilogram in 2022.

Supply Chain: China and India dominate manufacturing, with China supplying roughly 90% of exports. Excess capacity can suppress prices.

Product Quality and Certification: Regulatory compliance, especially in pharmaceutical applications, requires high purity standards (USP, EP, or BP grades). Certification costs can influence market entry.

Research & Development: Companies investing in manufacturing process improvements and novel applications (e.g., medical-grade variants, eco-friendly production) utilize R&D budgets averaging 3-5% of revenues.

What are the main risks and constraints?

  • Regulatory Changes: As pharmaceutical-grade sodium bicarbonate faces strict standards, delays or restrictions in approvals can impact supply.

  • Raw Material Cost Fluctuations: Energy prices directly influence manufacturing costs, with volatility occurring from geopolitical tensions or supply disruptions.

  • Environmental Regulations: Stricter waste disposal and emissions policies increase compliance costs and may limit production or require technology upgrades.

What are the investment implications?

Investors should consider the high geographic concentration of manufacturing in China, exposure to raw material cost swings, and the evolving regulatory landscape. The market’s growth hinges on rising healthcare demands and expansion into new industrial segments like environmental management. Companies with differentiated product offerings, strong certifications, and supply chain resilience will likely outperform.

Key Takeaways

  • The sodium bicarbonate market reached approximately $1.2 billion in 2022, with growth driven by healthcare, food, and industrial segments.
  • Projected CAGR of 4.3% from 2023 to 2030 suggests steady expansion.
  • Regional dynamics favor North America and Europe, with rapid growth in Asia-Pacific.
  • Price competitiveness, supply chain robustness, and regulatory compliance significantly influence competitive positioning.
  • Environmental and raw material risks require careful management to sustain growth.

5 FAQs

Q1: What are the main industrial uses of sodium bicarbonate outside pharmaceuticals?
It is primarily used in cleaning products, as a fire extinguishing agent, and in textile finishing.

Q2: How does regulatory oversight impact the pharmaceutical-grade sodium bicarbonate market?
Stringent purity standards and certification processes can delay product approvals and increase manufacturing costs.

Q3: Which regions offer the highest growth potential?
Asia-Pacific, particularly China and India, due to their expanding industrial infrastructure and pharmaceutical production capacity.

Q4: How sensitive is the market to raw material costs?
Highly sensitive, since raw materials like sodium compounds and energy inputs directly influence manufacturing expenses.

Q5: Are there significant innovation trends in sodium bicarbonate manufacturing?
Yes. Companies invest in process improvements that enhance purity, reduce costs, and develop specialized grades for medical and environmental applications.

References

[1] Market Research Future. (2023). Sodium bicarbonate market forecast.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.